Jean-Claude GUILLEMOT

Dernières Publications

1. Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay. (2019)
   Ferreira-Ramos AS, Li C, Eydoux C, Contreras JM, Morice C, Querat G, Gigante A, Perez Perez MJ, Jung ML, Canard B, Guillemot JC , Decroly E, Coutard B
   Antiviral Res 163 59-69
2. Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors. (2018)
   Halby L, Marechal N, Pechalrieu D, Cura V, Franchini DM, Faux C, Alby F, Troffer-Charlier N, Kudithipudi S, Jeltsch A, Aouadi W, Decroly E, Guillemot JC , Page P, Ferroud C, Bonnefond L, Guianvarc'h D, Cavarelli J, Arimondo PB
   Philos Trans R Soc Lond B Biol Sci 373
3. Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay. (2017)
   Aouadi W, Eydoux C, Coutard B, Martin B, Debart F, Vasseur JJ, Contreras JM, Morice C, Querat G, Jung ML, Canard B, Guillemot JC , Decroly E
   Antiviral Res 144 330-339
4. The Zika virus methyltransferase: structure and functions for drug design perspectives. (2017)
   Coutard B, Barral K, Lichiere J, Selisko B, Martin B, Aouadi W, Ortiz Lombardia M, Debart F, Vasseur JJ, Guillemot JC , Canard B, Decroly E
   J Virol 91 e02202-16
5. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase. (2016)
   Benmansour F, Eydoux C, Querat G, de Lamballerie X, Canard B, Alvarez K, Guillemot JC , Barral K
   Eur J Med Chem 109 146-56